TRELLUS HEALTH LS -0006 Total Liabilities
TRELLUS HEALTH LS -0006 total liabilities. Based on the latest financial reports, TRELLUS HEALTH LS -0006 (85Q) has total liabilities worth €513.00K EUR (≈ $599.75K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See 85Q cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Total Liabilities of TRELLUS HEALTH LS -0006 (2021–2024)
Total liabilities of TRELLUS HEALTH LS -0006 from 2021 to 2024. This chart illustrates how TRELLUS HEALTH LS -0006's total liabilities have evolved over time, based on quarterly financial data.
TRELLUS HEALTH LS -0006 Competitors by Total Liabilities
The table below lists competitors of TRELLUS HEALTH LS -0006 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Investor Centre Ltd
AU:ICU
|
Australia | AU$3.25 Million |
|
UMT United Mobility Technology AG
XETRA:UMDK
|
Germany | €4.28 Million |
|
Gangotri Textiles Limited
NSE:GANGOTRI
|
India | Rs2.52 Billion |
|
NEXTLEAF SOLUTIONS
F:L0MA
|
Germany | €3.95 Million |
|
Kiromic Biopharma Inc
NASDAQ:KRBP
|
USA | $21.13 Million |
|
Conygar Investment Co PLC
LSE:CIC
|
UK | GBX45.07 Million |
|
Rajvir Industries Limited
NSE:RAJVIR
|
India | Rs1.13 Billion |
|
Rua Life Sciences PLC
LSE:RUA
|
UK | GBX1.89 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down TRELLUS HEALTH LS -0006's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 85Q asset base.
Liquidity & Leverage Metrics
TRELLUS HEALTH LS -0006 Total Liabilities Ratios Explained
TRELLUS HEALTH LS -0006 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how TRELLUS HEALTH LS -0006's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for TRELLUS HEALTH LS -0006 (2021–2024)
The table below shows the annual total liabilities of TRELLUS HEALTH LS -0006 from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €371.00K ≈ $433.74K |
-52.80% |
| 2023-12-31 | €786.00K ≈ $918.92K |
-4.38% |
| 2022-12-31 | €822.00K ≈ $961.00K |
-45.96% |
| 2021-12-31 | €1.52 Million ≈ $1.78 Million |
-- |
About TRELLUS HEALTH LS -0006
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated… Read more